Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer.

Source:http://linkedlifedata.com/resource/pubmed/id/11297608

Download in:

View as

General Info

PMID
11297608